Tepawel 15mg Injection
Marketer
Getwell Pharma (I) Pvt Ltd
Salt Composition
Thiotepa (15mg)
Overview Tepawel 15mg Injection
Oncaspar 15mg Injection combats brain, breast, lung, and ovarian cancers. Administered alongside other anti-cancer drugs during hematopoietic stem cell transplantation (HSCT), its use may extend to other conditions as directed by a physician. Oncaspar 15mg Injection is always administered under medical supervision. Dosage and treatment length are tailored to individual needs and diagnosis. Therapeutic effects might not be apparent for weeks or months; discontinue only upon physician instruction. Frequently reported side effects include leukopenia, anemia, thrombocytopenia, elevated liver enzymes, hyperbilirubinemia, mucositis, bleeding, diarrhea, hematuria, and skin rashes. Reduced blood cell counts increase infection risk, necessitating regular blood tests monitoring blood cell levels, kidney, liver, and heart function throughout treatment. Prior to commencing treatment, disclose any bleeding disorders, liver or kidney impairment, or concurrent use of antimicrobial medications. Drug interactions are possible; inform your doctor of all medications. This injection is contraindicated during pregnancy and breastfeeding. Effective contraception is crucial for both partners during the treatment period to prevent conception.
Uses of Tepawel 15mg Injection
Malignancies of the brain, breast, lung (non-small cell), and ovary.
Major Benefits of Tepawel 15mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
Common Side effects of Tepawel 15mg Injection:
- Decreased white blood cell count (neutrophils)
- Anemia (low number of red blood cells)
- Low blood platelets
- Increased liver enzymes
- Increased bilirubin in the blood
- Mucosal inflammation
- Hemorrhage
- Rash
- Diarrhea
- Blood in urine
How to use Tepawel 15mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Tepawel 15mg Injection works:
The injectable formulation of Tepawel, 15mg, is a cancer therapeutic agent. Its mechanism of action involves disrupting the DNA and RNA of malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tepawel 15mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Tepawel 15mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Tepawel 15mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Tepawel 15mg Injection may induce adverse reactions that impair driving capabilities. Dizziness, headache, and blurred vision are potential side effects of Tepawel 15mg Injection, and these could compromise safe driving.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Tepawel 15mg Injection is likely safe. Available evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Tepawel 15mg Injection cautiously, potentially requiring a modified dosage. A physician's consultation is recommended. Routine liver function testing may be necessary during treatment.
What if you forget to take Tepawel 15mg Injection :
Should you forget a Tepawel 15mg Injection dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tepawel 15mg Injection
| Label | Value |
|---|---|
| Chemical Type | Thiophosphate Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | Alkylating substance |


